Could I have a statement, please? http://www.taketwopodcast.com/stmap_58n82qz.html?prandin.cialis.toprol.unisom knm pharmacy  German drugmaker Merck KGaA will conduct new testson an experimental lung cancer vaccine which failed a previouslate-stage clinical trial, it said. The drug, licensed from U.S.biotech firm Oncothyreon, will be tested on patients withlocally advanced Stage III non-small cell lung cancer, whichcannot be surgically removed, unchanged from the previous trialcalled START, the firm said.